SCHEMBL4338093

SCHEMBL4338093

Cc1ccc(NC(=O)OCc2cccc(CC(C(=O)O)C(=O)O)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
NPC1 O15118 4/20 0.50
RAB9A P51151 4/20 0.50
MGLL Q99685 2/20 0.49
POLB P06746 1/20 0.48
TP53 P04637 3/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPT P10636 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM1A O60341 2/20 0.44
MAOA P21397 2/20 0.44
MAOB P27338 2/20 0.44
ENPP2 Q13822 1/20 0.44
TSHR P16473 1/20 0.44
ATM Q13315 1/20 0.44
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ROCK2 O75116 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13810335 0.91 MEN1 (0.55) MEN1KMT2ANPC1RAB9AMGLL
SCHEMBL4341257 0.90 MGLL (0.60) MEN1KMT2ANPC1RAB9AMGLL
SCHEMBL4328095 0.88 MGLL (0.51) MEN1KMT2ANPC1RAB9AMGLL
SCHEMBL4333325 0.88 FPR2 (0.54) MEN1KMT2ANPC1RAB9AMGLL
SCHEMBL4341927 0.88 MEN1 (0.53) MEN1KMT2ANPC1RAB9AMGLL
SCHEMBL4339291 0.86 MEN1 (0.50) MEN1KMT2ANPC1RAB9AMGLL
SCHEMBL4333321 0.84 MGLL (0.60) MEN1KMT2AMGLLPOLBTP53
SCHEMBL13810333 0.84 MGLL (0.56) MEN1KMT2ANPC1RAB9AMGLL
SCHEMBL5852207 0.82 POLB (0.68) MEN1KMT2ANPC1RAB9AMGLL
SCHEMBL4333262 0.82 USP2 (0.54) MEN1KMT2ANPC1RAB9AMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 MEN1 4091/4885KMT2A 2774/4885NPC1 603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.